Miriam A. Casamayor-Cela
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 28, 2024
Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents.
Journal: Drug delivery and translational research
Published: March 18, 2024
Topical Insulin Eye Drops: Stability and Safety of Two Compounded Formulations for Treating Persistent Corneal Epithelial Defects.
Journal: Pharmaceutics
Published: February 22, 2024
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost.
Journal: The ocular surface
Published: March 09, 2023
A novel osmoprotective liposomal formulation from synthetic phospholipids to reduce in vitro hyperosmolar stress in dry eye treatments.
Journal: Journal of liposome research
Published: June 16, 2022
Development of an osmoprotective microemulsion as a therapeutic platform for ocular surface protection.
Journal: International journal of pharmaceutics
Published: March 27, 2022
Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments.
Journal: Experimental eye research
Published: June 09, 2021
Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
Journal: Expert opinion on drug delivery
Published: January 08, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026